Among adults receiving adalimumab, patients with HS had a greater risk for hospitalization due to infections than patients with PsO.

Sustained two-year treatment with tildrakizumab improved the psychological well-being of people with moderate to severe ...

Colorado became the first state in the nation to set a price cap on a specific medication last week, following a unanimous ...

A 16-week Mediterranean diet intervention significantly improved psoriasis severity and metabolic health in adults with mild to moderate psoriasis. The study demonstrated a notable reduction in ...

Meditation, biofeedback, aromatherapy, and other such therapies can relieve stress caused by psoriasis and fend off stress-triggered flares.

Obesity and the proinflammatory state are sufficiently tied to psoriasis and HS that GLP-1 agonists should be considered within multifaceted care, experts say.

A groundbreaking technology developed by Heriot-Watt University has received over £475,000 in funding to revolutionize how ...

A 16-week Mediterranean diet intervention significantly improves psoriasis severity in patients with mild-to-moderate disease receiving stable topical therapy.

The FDA approved a supplemental new drug application for Tremfya for the treatment of children aged 6 years or older with ...

Guselkumab is the first IL-23 inhibitor approved for pediatric plaque psoriasis and active psoriatic arthritis, addressing a significant treatment gap. The PROTOSTAR study showed 56% of children on ...

HONOLULU KHON2) — Last night, Sept. 20, a fatal motor vehicle accident occurred, causing Oahu’s 62nd traffic fatality of 2025. A different accident left a pedestrian in critical condition. At ...